Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Novel Class of Psychedelic Iboga Alkaloids Disrupts Opioid Use

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.07.22.453441Source: DataRank Database

Novel Class of Psychedelic Iboga Alkaloids Disrupts Opioid Use is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: greenTopics (13)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Andrew C. Kruegel ORCID,Benjamin Bechand ORCID,Scot McIntosh ORCID,Leia S. Stallings,Alana Hodges

Live enrichment

PubMed:19162232 OpenAlex:https://openalex.org/W3185939656

National Institutes of Health

Grant: 5R33DA038858-04

Rational discovery of new DOR chemotypes to prevent addiction and overdose

National Institutes of Health

Grant: 1R21MH116462-01

Endogenous opioid system contributions to anti-depressant action

National Institutes of Health

Grant: 5R01DA050613-04

Chemistry and Pharmacology of Iboga Alkaloids

National Institutes of Health

Grant: 4R33DA045884-03

Pharmacological Probes based on mitragynine pseudoindoxyl

green

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2021/07/23/2021.07.22.453441.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.07.22.453441

repositoryhttps://doi.org/10.1101/2021.07.22.453441

Fields of Study

Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on BehaviorChemical synthesis and alkaloids0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

MedicinePharmacologyOpioidNeuroscienceInternal medicinePsychologyReceptor

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being